Structure and function of xanthine oxidoreductase: where are we now?
R Harrison - Free Radical Biology and Medicine, 2002 - Elsevier
Xanthine oxidoreductase (XOR) is a complex molybdoflavoenzyme, present in milk and
many other tissues, which has been studied for over 100 years. While it is generally …
many other tissues, which has been studied for over 100 years. While it is generally …
The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics
S Divakaran, J Loscalzo - Journal of the american college of cardiology, 2017 - jacc.org
The use of nitroglycerin in the treatment of angina pectoris began not long after its original
synthesis in 1847. Since then, the discovery of nitric oxide as a biological effector and better …
synthesis in 1847. Since then, the discovery of nitric oxide as a biological effector and better …
Impact of abnormal coronary reactivity on long-term clinical outcomes in women
A AlBadri, CN Bairey Merz, BD Johnson, J Wei… - Journal of the American …, 2019 - jacc.org
Background: Currently as many as one-half of women with suspected myocardial ischemia
have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is …
have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is …
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
JA Suwaidi, S Hamasaki, ST Higano, RA Nishimura… - Circulation, 2000 - Am Heart Assoc
Background—Coronary endothelial dysfunction is characterized by vasoconstrictive
response to the endothelium-dependent vasodilator acetylcholine. Although endothelial …
response to the endothelium-dependent vasodilator acetylcholine. Although endothelial …
Endothelium‐dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
JH Yang, M Obokata, YNV Reddy… - European journal of …, 2020 - Wiley Online Library
Background Coronary microvascular inflammation is hypothesized to play a fundamental
role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). No …
role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). No …
Sodium nitroprusside in 2014: A clinical concepts review
DG Hottinger, DS Beebe, T Kozhimannil… - Journal of …, 2014 - journals.lww.com
Sodium nitroprusside has been used in clinical practice as an arterial and venous
vasodilator for 40 years. This prodrug reacts with physiologic sulfhydryl groups to release …
vasodilator for 40 years. This prodrug reacts with physiologic sulfhydryl groups to release …
The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough
R Wiest, RJ Groszmann - Hepatology, 2002 - journals.lww.com
Chronic liver diseases are often characterized by portal hy-pertension, an important
component of which is increased intrahepatic vascular resistance (IHVR). We have long …
component of which is increased intrahepatic vascular resistance (IHVR). We have long …
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute–sponsored …
GO von Mering, CB Arant, TR Wessel, SP McGorray… - Circulation, 2004 - Am Heart Assoc
Background—Coronary vascular dysfunction has been linked to atherosclerosis and
adverse cardiovascular outcomes in men, but these relationships have not been firmly …
adverse cardiovascular outcomes in men, but these relationships have not been firmly …
Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
D Hasdai, RJ Gibbons, DR Holmes Jr, ST Higano… - Circulation, 1997 - Am Heart Assoc
Background Coronary endothelial dysfunction may occur in patients with minimally
obstructive coronary artery disease and angina, and potentially may cause myocardial …
obstructive coronary artery disease and angina, and potentially may cause myocardial …
Nitrate therapy for stable angina pectoris
JD Parker, JO Parker - New England Journal of Medicine, 1998 - Mass Medical Soc
The organic nitrates are widely used in the management of coronary artery disease. They
are given not only to patients with stable angina pectoris, but also to those with unstable …
are given not only to patients with stable angina pectoris, but also to those with unstable …